Aurz Pharmaceutical Private Limited, a active private limited company, was established on 05 November 2007 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KA2007PTC044290. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Employing 20 professional, Its leadership includes Nagasri Harish (Director), Munjamani Srinivasa Harish (Managing Director), Kavitha Madhusudhan (Director). Past directors included Nagasri Harish, Munjamani Srinivasa Harish, Vinod Rama Swamy. It holds ₹3.56 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 28/2, Govindappa Road Basavanagudi, Bangalore, Karnataka, 560004.
U24231KA2007PTC044290
044290
05 November 2007
₹2.50 M
₹2.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Aurz Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagasri Harish | Director | 04 Jul 2022 | Current |
| Munjamani Srinivasa Harish | Managing Director | 05 Nov 2007 | Current |
| Kavitha Madhusudhan | Director | 25 May 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Managing Director | 29 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 Sep 2013 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurz Pharmaceutical Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 15.99% decrease. The company also saw a substantial fall in profitability, with a 84.82% decrease in profit. The company's net worth Soared by an impressive increase of 16.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Aurz Pharmaceutical had a promoter holding of 95.65% and a public holding of 4.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,586,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 2024 | Canara Bank | ₹2.00 M | Open |
| 20 Jan 2024 | Canara Bank | ₹2.00 M | Open |
| 27 Nov 2023 | Canara Bank | ₹1.70 M | Open |
| 05 Oct 2016 | Others | ₹1.31 M | Open |
| 30 Mar 2013 | State Bank Of India | ₹1.75 Cr | Open |
Explore comprehensive loan charge details -
Aurz Pharmaceutical has a workforce of 20 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurz Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurz Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aurz Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Aurz Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on A charge with Canara Bank amounted to Rs. 2.00 M with Charge ID 100863783 was registered on 20 Jan 2024. was documented.
The activity A charge with Canara Bank amounted to Rs. 2.00 M with Charge ID 100863779 was registered on 20 Jan 2024. was completed.
Progress on A charge with Canara Bank amounted to Rs. 1.70 M with Charge ID 100847525 was registered on 27 Nov 2023. was documented.
Nagasri Harish was appointed as a Director was appointed as a Director on 04 Jul 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The CIN of Aurz Pharmaceutical Private Limited is U24231KA2007PTC044290.
Aurz Pharmaceutical Private Limited is headquartered at No. 28/2, Govindappa Road Basavanagudi, Bangalore, Karnataka, 560004.
Aurz Pharmaceutical Private Limited was incorporated on 05 November 2007.
The current directors of Aurz Pharmaceutical Private Limited are
The primary industry of Aurz Pharmaceutical Private Limited is Manufacturing.
Aurz Pharmaceutical Private Limited is unlisted.
The authorized capital of Aurz Pharmaceutical Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Aurz Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX